The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative efficacy of linvoseltamab versus teclistamab in triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM): Updated matching-adjusted indirect comparison (MAIC) with longer follow-up.
 
Hans Lee
Consulting or Advisory Role - Abbvie (Inst); Alexion Pharmaceuticals; Allogene Therapeutics; Bristol Myers Squibb; GlaxoSmithKline; Janssen Research & Development; Legend Biotech (Inst); Menarini Silicon Biosystems; Pfizer; Predicta (Inst); Regeneron; Sanofi; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Moderna Therapeutics (Inst); Regeneron (Inst); Takeda (Inst)
 
Naresh Bumma
Honoraria - Regeneron
Consulting or Advisory Role - Janssen
 
Joshua Richter
No Relationships to Disclose
 
Jeffrey Zonder
Employment - Bristol-Myers Squibb (I)
Consulting or Advisory Role - Alexion Pharmaceuticals; Bristol-Myers Squibb; Janssen; Opna Bio; Pfizer; Prothena; Regeneron
Research Funding - Bristol-Myers Squibb; Janssen; RLL LLC
 
James Hoffman
No Relationships to Disclose
 
Zheng-Yi Zhou
Other Relationship - I am an employee of Analysis Group, Inc., which received funding from Regeneron for the conduct of this study.
 
Viviana Horton
Other Relationship - I am an employee of Analysis Group, Inc., which received funding from Regeneron for the conduct of this study.
 
Mirko Fillbrunn
Other Relationship - I am an employee of Analysis Group, Inc., which received funding from Regeneron for the conduct of this study.
 
Hongjue Wang
Other Relationship - I am an employee of Analysis Group, Inc., which received funding from Regeneron for the conduct of this study.
 
Matthew Mattera
Other Relationship - I am an employee of Analysis Group, Inc., which received funding from Regeneron for the conduct of this study.
 
Wenxin Ma
Other Relationship - I am an employee of Analysis Group, Inc., which received funding from Regeneron for the conduct of this study.
 
Timothy Inocencio
Employment - Regeneron Pharmaceuticals. Inc.
Stock and Other Ownership Interests - Regeneron Pharmaceuticals. Inc.
 
Yingxin Xu
Employment - Regeneron Pharmaceuticals. Inc.
Stock and Other Ownership Interests - Regeneron Pharmaceuticals. Inc.
 
James Harnett
Employment - Regeneron
Stock and Other Ownership Interests - Pfizer; Regeneron
 
Tito Roccia
Employment - Regeneron Pharmaceuticals. Inc.
Stock and Other Ownership Interests - Regeneron Pharmaceuticals. Inc.
 
Kate Knorr
No Relationships to Disclose
 
Glenn Kroog
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Research Funding - Regeneron
Travel, Accommodations, Expenses - Regeneron
 
Karen Rodriguez Lorenc
Employment - Regeneron Pharmaceuticals. Inc.
Stock and Other Ownership Interests - Regeneron Pharmaceuticals. Inc.
 
Qiufei Ma
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Sundar Jagannath
Consulting or Advisory Role - Bristol-Myers Squibb; Caribou Biosciences; Genmab; GlaxoSmithKline; Janssen; Legend Biotech; Poseida; Regeneron; Sanofi; Takeda
Travel, Accommodations, Expenses - Brystol-Myers Squibb; Internation Myeloma Society; Janssen Biotech; Poseida; Regeneron